pCLL_0004 |
Hypothetical protein |
Hypothetical protein, C. perfringens pCP13, PCP53, and conserved hypothetical, C. perfringens E str. JGS1987, CPC_A0335, 53/78 (67%) |
78 |
717–953 |
pCLL_0005 |
VirD4 component |
TraG/TraD family, C. perfringens D str. JGS1721, CJD_A0258, 383/747 (51%) |
739 |
1017–3236 |
pCLL_0006 |
Hypothetical protein |
Putative membrane protein, C. perfringens C str. JGS1495, CPC_A0332, 162/353 (45%), hypothetical protein C. perfringens pCP13, PCP50, 162/353 (45%) |
711 |
3241–5376 |
pCLL_0007 |
Hypothetical protein |
Hypothetical protein, C. perfringens pCP13, PCP49, 47/87 (54%) |
91 |
5377–5652 |
pCLL_0008 |
Hypothetical protein |
Hypothetical protein, C. perfringens pCP13, PCP48, 66/124 (53%) |
138 |
5764–6402 |
pCLL_0009 |
Hypothetical protein |
Conserved hypothetical, C. perfringens C str. JGS1495, CPC_A0328, 406/627 (64%) |
637 |
6458–8371 |
pCLL_0010 |
Hypothetical protein |
Hypothetical protein, C. perfringens pCP13, PCP45, 55/161 (34%) |
167 |
8373–9053 |
pCLL_0011 |
Probable cell wall-binding protein |
Probable cell wall-binding protein, C. perfringens E str. JGS1987, AC3_A0050, 224/370 (60%), TcpG, C. perfringens C str. JGS1495, CPC_A0146, 83/134 (61%) |
389 |
9114–10283 |
pCLL_0012 |
Hypothetical protein |
Conserved hypothetical protein, C. perfringens D str. JGS1721, CJD_1944, 106/267 (39%) |
270 |
10302–11114 |
pCLL_0013 |
Hypothetical protein |
Conserved hypothetical protein, C. perfringens C str. JGS1495, CPC_A0323, 42/82 (51%) |
91 |
11397–11672 |
pCLL_0014 |
Hypothetical protein |
Conserved hypothetical protein, C. perfringens D str. JGS1721, CJD_A0233, 48/123 (39%) |
136 |
11678–12088 |
pCLL_0015 |
Hypothetical protein |
Conserved hypothetical protein, C. perfringens C str. JGS1495, CPC_A0321, 200/377 (53%) |
379 |
12102–13241 |
pCLL_0016 |
Hypothetical protein |
Conserved hypothetical protein, C. perfringens D str. JGS1721, CJD_A0227, 55/116 (47%) |
365 |
13267–14388 |
pCLL_0017 |
Conserved hypothetical protein |
Hypothetical protein, C. perfringens str. 13 pCP13, PCP34, 31/74 (41%) |
171 |
14453–14968 |
pCLL_0040 |
Resolvase/recombinase |
Resolvase/Recombinase, C. perfringens D str. JGS 1721, CJD_1891, 78/210 (37%) |
210 |
33462–34094 |
pCLL_0042 |
Site-specific recombinase resolvase family |
DNA-invertase, C.perfringens CPE str. F4969, AC5_A0225, 80/191 (41%) |
181 |
34265–34810 |
pCLL_0045 |
Replication protein |
Replication protein, C. perfringens B str. ATCC 3626, AC1_A0161, 164/388 (42%) |
446 |
35980–37320 |
pCLL_0047 |
Putative ATPase |
Putative ATPase, C. perfringens E str. JGS1987, AC3_0198, 145/302 (48%) |
297 |
38545–39438 |
pCLL_0048 |
Hypothetical protein |
Hypothetical protein, C. perfringens E str. JGS1987, AC3_0197, 21/41 (51%) |
119 |
39431–39790 |
pCLL_0051 |
Putative LexA repressor |
LexA repressor, C. perfringens B str. ATCC 3626, AC1_A0290, 34/78 (43%) |
235 |
40570–41277 |
pCLL_0053 |
Hypothetical protein |
Conserved hypothetical protein, C. perfringens B str. ATCC 3626 AC1_A0334, 33/105 (31%) |
120 |
41747–42109 |
pCLL_0056 |
Cell wall binding repeat domain protein |
Cell wall binding repeat domain protein, C. perfringens D str. JGS1721, CJD_0682, 83/183 (45%) |
152 |
42953–47533 |